Prolaris Blog

Recent posts

May 13, 2022 | Patient Blog

What is a Gleason Score

Pathologists review biopsy tissue and assign it a Gleason grade based on the appearance of the cells. If cancer is […]
May 6, 2022 | Patient Blog

Understanding PSA
April 29, 2022 | Patient Blog

Prostate cancer on the rise in 2022
March 25, 2022 | Physician Blog

Genetic insights for more actionable and personalized prostate cancer
February 11, 2022 | Physician Blog

Prolaris® is advancing prostate cancer care at ASCO GU
November 2, 2021 | Physician Blog

Prolaris® is Helping Urologists Reimagine Prostate Cancer Care
October 15, 2021 | Physician Blog

New Study Proves that Prolaris can Determine which Patients Can Safely Avoid ADT
April 15, 2021 | Patient Blog

2021 Prostate Cancer Statistics
February 17, 2021 | Physician Blog

New Data Validating the Prolaris® Test to Guide Treatment for Prostate Cancer
September 28, 2020 | Patient Blog

The Importance of Genetic Testing for Prostate Cancer P2
September 17, 2020 | Patient Blog

The Importance of Genetic Testing for Prostate Cancer P1
September 17, 2020 | Physician Blog

1 in 6 Men with Prostate Cancer May Have a Hereditary, Disease-Causing Mutation
September 9, 2020 | Patient Blog

The Prolaris Test Gave Me Information I Needed
September 9, 2020 | Physician Blog

New Treatment Options Available
September 4, 2020 | Patient Blog

Genetic Testing Changed My Life
September 1, 2020 | Physician Blog

Medicare Expands Coverage for BRACAnalysis CDx in Prostate Cancer